Mace Head Atmospheric Research Station

ShareInvestor Group's S$30M Merger with InvestingNote Adds Vitality to Singapore's Retail Investing Scene

Retrieved on: 
Wednesday, January 4, 2023

The deal terms for the merger values the combined Group at more than S$30 million.

Key Points: 
  • The deal terms for the merger values the combined Group at more than S$30 million.
  • Shanison's belief that financial literacy should be fun and profitable has powered Investing Note to be the largest social network for young retail investors in both Singapore and Malaysia.
  • Mr Christopher Lee, CEO, ShareInvestor Group said: "The merger with InvestingNote is a natural progression for ShareInvestor given our long and synergistic relationship.
  • The merger between ShareInvestor and InvestingNote will combine talents and capabilities of both platforms and broaden their reach to investors in the region.

EQS-News: Advanced Blockchain AG: Incubation Panoptic successfully closes USD 4.5 million funding round

Retrieved on: 
Sunday, December 18, 2022

Advanced Blockchain AG (Scale, Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6) announced that its recently spun-off project Panoptic was able to raise USD 4.5 million for the further development of its protocol.

Key Points: 
  • Advanced Blockchain AG (Scale, Frankfurt, Primary Market Düsseldorf, XETRA: ISIN DE000A0M93V6) announced that its recently spun-off project Panoptic was able to raise USD 4.5 million for the further development of its protocol.
  • Gumi Cryptos Capital (gCC) led the funding round, followed by Uniswap Labs Ventures, Coinbase Ventures, Jane Street, the Avalanche Foundation's Blizzard Fund and other notable investors.
  • In exchange for the initial development services and internally generated intellectual property, Advanced Blockchain AG received a high six-figure one-time payment, an equity stake in Panoptic, and a warrant for future tokens.
  • The Panoptic protocol was developed by Advanced Blockchain AG's Head of Research, Jesper Kristensen, in collaboration with its Co-Founder, Guillaume Lambert.

Sygnum launches first institutional crypto sector indices

Retrieved on: 
Sunday, December 18, 2022

Zurich, 15 December 2022 – Sygnum launches the first phase of its crypto sector investment strategy, a range of rules-based sector indices and tools designed to meet the evolving needs of institutional investors.

Key Points: 
  • Zurich, 15 December 2022 – Sygnum launches the first phase of its crypto sector investment strategy, a range of rules-based sector indices and tools designed to meet the evolving needs of institutional investors.
  • The Sygnum research report “Crypto Sector Indices” and crypto sector snapshots can be downloaded here.
  • A comprehensive range of multi and single crypto sector investment solutions leveraging the core sector indices will be rolled-out from Q1 2023 for professional and institutional investors.
  • “The Sygnum crypto sector indices set new standards for institutional analysis, transparency and understanding of the crypto market.

BentoBox Partners with Award-Winning Chef Chris Shepherd to Announce Inaugural National Restaurant Workers Day, Honoring and Supporting Restaurant Workers

Retrieved on: 
Tuesday, December 13, 2022

NEW YORK, Dec. 13, 2022 /PRNewswire/ -- BentoBox, the restaurant technology company that partners with over 14,000 restaurants worldwide, and James Beard award-winning Chef Chris Shepherd today announced the first-ever National Restaurant Workers Day, commencing on December 14th, where diners will be inspired and encouraged to honor, support and appreciate restaurant workers across the country this holiday season.

Key Points: 
  • To kick-off the inaugural National Restaurant Workers Day, BentoBox is launching a partnership with Shepherd's Southern Smoke Foundation , a non-profit, crisis-relief organization for food and beverage workers.
  • Together, with the support of these industry champions, BentoBox looks to motivate diners and restaurant owners to join the movement, recognize the systemic challenges that restaurant workers face and celebrate National Restaurant Workers Day.
  • We're looking forward to kicking off the first-ever National Restaurant Workers Day and keeping the tradition alive for many years to come."
  • It's our way of showing our appreciation and celebrating restaurant workers across the country, who we interact with everyday," said Shepherd.

Living Security Announces Additions to its CISO Advisory Board

Retrieved on: 
Tuesday, December 6, 2022

AUSTIN, Texas, Dec. 6, 2022 /PRNewswire/ -- Living Security, the leader in Human Risk Management, today announced the addition of four widely respected experts to its Chief Information Security Officer (CISO) Advisory Board. They join a group of well-known experts across various industries, including, healthcare, education, and retail, who are advising the company as it continues its push to revolutionize the cybersecurity industry with a proactive approach to Human Risk Management.

Key Points: 
  • "The security leaders joining our CISO Advisory Board are on the front lines of cybersecurity across industries that are the most impacted by attacks.
  • Living Security's new CISO Advisory Board members include:
    They join current board members: Allan Alford, President & CISO at Allan Alford Consulting and The Cyber Ranch Podcast; Summer Craze Fowler, Chief Corporate Responsibility Officerat Argo AI; Omar Khawaja, CISO at Highmark Health; Brian Markham, CISO at EAB Global; Yael Nagler, Founder at Yass Partners; Aurobindo Sundaram, Head of Information Assurance & Data Protection at RELX; Dan Walsh, CISO at VillageMD; Marnie Wilking, CISO at Wayfair; Sounil Yu, CISO and Head of Research at JupiterOne.
  • Living Security's mission is to transform human risk to drive dramatic improvement in human behaviors, organizational security culture, and infosec program effectiveness.
  • Living Security is trusted by security-minded organizations like MasterCard, Verizon, MassMutual, Biogen, AmerisourceBergen, Hewlett Packard, and Target.

BlocksBridge Launches TheMinerMag to Set New Standards of Research and Transparency for Bitcoin Mining

Retrieved on: 
Saturday, December 3, 2022

NEW YORK, Dec. 3, 2022 /PRNewswire/ -- BlocksBridge Consulting ("BlocksBridge"), the consulting and advisory firm for institutions in the bitcoin mining industry, today launched TheMinerMag, a data and research resource for journalists, analysts, industry executives and anyone interested in coherent and decisive information on Nasdaq-listed bitcoin mining companies.

Key Points: 
  • TheMinerMag is for journalists, analysts, and anyone interested in decisive information on bitcoin mining companies.
  • Wolfie brings a wealth of experience to BlocksBridge: he has been involved in the bitcoin mining space since 2017.
  • Most recently he was a bitcoin mining analyst at The Block Research, where he oversaw mining research and consulting for funds and investors interested in bitcoin mining.
  • "I have no doubt that with Wolfie at the helm, TheMinerMag will play an important role in setting higher standards of reporting and transparency in the bitcoin mining industry."

Congruence Therapeutics Strengthens Leadership Team with Appointment of Dr. Sharath Hegde as Chief Scientific Officer

Retrieved on: 
Tuesday, November 22, 2022

MONTREAL, Nov. 22, 2022 /PRNewswire/ -- Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding, announced today the appointment of Sharath S. Hegde, Ph.D. as Chief Scientific Officer. 

Key Points: 
  • "I am thrilled to welcome Sharath to Congruence as Chief Scientific Officer.
  • Prior to joining Congruence, Dr. Hegde was Chief Scientific Officer at Herophilus, a technology enabled neurotherapeutics company, where he established the company's drug-discovery strategy and advanced their Rett syndrome project into late discovery.
  • Before that, Sharath was Chief Scientific Officer of Recursion, a machine-learning and technology-enabled clinical-stage biotechnology company with a broad pipeline.
  • Dr. Borsuk joins Congruence from Sitryx Therapeutics, where she served as Chief Business Officer.

Believe and TuneCore Announce Third Annual BE THE CHANGE: Gender Equality Study

Retrieved on: 
Monday, November 21, 2022

NEW YORK, Nov. 21, 2022  /PRNewswire-PRWeb/ -- Believe, one of the world's leading digital music companies and its automated distribution company for self-releasing artists, TuneCore, announced the third installment of their annual BE THE CHANGE: Gender Equality Study. This year, Believe and TuneCore have engaged entertainment data and insights company Luminate to lead the research for the study and expand its scope. That includes an increased focus on global reach, with plans to have the study translated into 13 languages, and an emphasis on intersectionality, approaching issues of gender inequality through an even more diverse lens across gender minorities.

Key Points: 
  • This year, Believe and TuneCore have engaged entertainment data and insights company Luminate to lead the research for the study and expand its scope.
  • That includes an increased focus on global reach, with plans to have the study translated into 13 languages, and an emphasis on intersectionality, approaching issues of gender inequality through an even more diverse lens across gender minorities.
  • Andreea Gleeson, Chief Executive Officer, TuneCore commented, "To enact meaningful change, each of us must make a concerted, continuous effort to learn, educate, and take direct action for gender equality.
  • Believe offers its various solutions through a portfolio of brands including TuneCore, Nuclear Blast, Nave, Groove Attack and AllPoints.

Sapience Therapeutics Presents Data on the Immune Activating Function of ST101 at Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

Retrieved on: 
Thursday, November 10, 2022

Validating these findings, subtherapeutic doses of ST101 significantly enhanced the anti-tumor activity of anti-PD1 antibodies in an orthotopic breast cancer tumor model.

Key Points: 
  • Validating these findings, subtherapeutic doses of ST101 significantly enhanced the anti-tumor activity of anti-PD1 antibodies in an orthotopic breast cancer tumor model.
  • Sapience believes that reprogramming MDSCs from the M2 to the M1 phenotype represents a potential strategy to enhance antitumor immunity.
  • Further details of the ST101 mechanism of action can be found on the company's website: ST101: Sapience Therapeutics, Inc.
  • Sapience Therapeutics, Inc. is a privately held, clinical-stage biotechnology company focused on discovering and developing peptide therapeutics to address oncogenic and immune dysregulation that drive cancer.

Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium

Retrieved on: 
Wednesday, October 26, 2022

Vijaya G. Tirunagaru, Ph.D., Sr. Vice President and Head of Research, Rain Therapeutics, Newark, CA

Key Points: 
  • Vijaya G. Tirunagaru, Ph.D., Sr. Vice President and Head of Research, Rain Therapeutics, Newark, CA
    A copy of the presentation materials can be accessed by visiting the " Resources section of the Rain website after the conclusion of the presentation and will be archived on the Rain website.
  • Rain Therapeutics Inc. is a late-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit.
  • This approach includes using a tumor-agnostic strategy to select patients based on their tumors underlying genetics rather than histology.
  • In addition to milademetan, Rain is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.